Seeing Is Believing
ACRV is currently covered by 1 analysts with an average price target of $17.09. This is a potential upside of $14.56 (575.49%) from yesterday's end of day stock price of $2.53.
Acrivon Therapeutics, Common Stock's activity chart (see below) currently has 33 price targets and 27 ratings on display. The stock rating distribution of ACRV is 100% BUY.
Highest price target for ACRV is $19, Lowest price target is $19, average price target is $19.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 25-Nov-2025. First documented stock forecast 09-Dec-2022.
Currently out of the existing stock ratings of ACRV, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$19
$16.64 (705.08%)
$22
18 days ago
(25-Nov-2025)
0/9 (0%)
$16.68 (718.97%)
Buy
$27
$24.64 (1044.07%)
$28
1 years 29 days ago
(14-Nov-2024)
0/6 (0%)
$19.08 (240.91%)
Buy
$17
$14.64 (620.34%)
$17
1 years 2 months 27 days ago
(16-Sep-2024)
0/4 (0%)
$8.77 (106.56%)
Buy
$16
$13.64 (577.97%)
1 years 2 months 27 days ago
(16-Sep-2024)
0/2 (0%)
$7.77 (94.41%)
Buy
$30
$27.64 (1171.19%)
$25
1 years 7 months 18 days ago
(25-Apr-2024)
0/2 (0%)
$21.53 (254.19%)
What is ACRV (Acrivon Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on ACRV (Acrivon Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on ACRV (Acrivon Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on ACRV (Acrivon Therapeutics, Common Stock)?
Which analyst is the currently most bullish on ACRV (Acrivon Therapeutics, Common Stock)?
Which analyst is the currently most reserved on ACRV (Acrivon Therapeutics, Common Stock)?